Delivery Order SPE2DR25D1103-SPE2DR26FE431
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Zepbound 5 mg/0.5 mL pen injectors valued at $39,954.71, with completion scheduled for December 2, 2025. This competitive award with firm fixed pricing represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The...
- The Defense Logistics Agency awarded a $4,273.44 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Zepbound 10 mg/0.5 mL pen injectors with an ultimate completion date of August 18, 2025. This is a non-set-aside competitive award leveraging AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle that runs through December 2026....
- The Defense Logistics Agency awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Zepbound 10 mg/0.5 mL pen injectors with a ceiling value of $1,845.70 and an ultimate completion date of December 2, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $1 billion and extending through December 2026. The...
- The Defense Logistics Agency has awarded a delivery order valued at $2,161.10 to AmerisourceBergen Drug Corp for the supply of Zepbound 10 mg/0.5 mL pen injectors. This firm fixed price, non-set-aside contract was executed on December 17, 2025, with an ultimate completion date of December 18, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a $11,425.65 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Zepbound 10 mg/0.5 mL pen injectors on November 25, 2025, with an ultimate completion date of November 26, 2025. This non-set-aside award represents a delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The pharmaceutical distributor,...
- The Defense Logistics Agency awarded a $20,062.40 delivery order to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 ml pen injectors on November 25, 2025, with completion targeted for November 26, 2025. This firm fixed-price delivery order, issued without set-aside designation, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract action under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $15,814 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 mL pen injectors on November 12, 2025, with an ultimate completion date of November 13, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $13,494.22 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 mL pen injections on December 14, 2025, with an ultimate completion date of December 15, 2025. This non-competitive, firm fixed-price delivery order is being performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order valued at $3,886.65 to AmerisourceBergen Drug Corp for the supply of Zepbound 10 mg/0.5 mL pen injectors on September 5, 2025, with an ultimate completion date of September 8, 2025. This firm fixed-price, non-set-aside delivery order will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a child contract executed under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $12,721.80 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 ml pen injectors on November 7, 2025, with an ultimate completion date of November 10, 2025. This competitively awarded, firm fixed-price contract represents a non-set-aside procurement fulfilled by the pharmaceutical distributor's corporate office located in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen Drug Corp's...
- SPE2DR25D1103Indefinite Delivery Contract
- SPE2DR25D1103-SPE2DR26FE431Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,262.60 to AmerisourceBergen Drug Corp for the supply of Zepbound 10 mg/0.5 mL pen injectors on December 17, 2025, with completion scheduled for December 18, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), a comprehensive $999,999,999.00 vehicle running through December 2026 that enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp serves as a critical vendor within the federal medical procurement supply chain, leveraging its position as a major pharmaceutical distributor to fulfill federal healthcare requirements across multiple therapeutic domains. The company's extensive portfolio of DLA contract awards demonstrates its capability to deliver diverse pharmaceutical products ranging from specialty medications to vaccines and medical devices. This particular delivery order for Zepbound, a diabetes medication, exemplifies the company's ongoing role in supplying brand-name pharmaceuticals to support Defense Health Agency operations and other federal healthcare systems through flexible, competitively-awarded contracting mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.3k | 12/16/25 |